Saluda Medical, Inc. (ASX:SLD)
Australia flag Australia · Delayed Price · Currency is AUD
1.270
-1.380 (-52.08%)
At close: Dec 5, 2025

Saluda Medical Statistics

Total Valuation

Saluda Medical has a market cap or net worth of AUD 320.07 million. The enterprise value is 899.19 million.

Market Cap320.07M
Enterprise Value 899.19M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

Saluda Medical has 252.02 million shares outstanding.

Current Share Class n/a
Shares Outstanding 252.02M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 4.13
PB Ratio 7.11
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a

Enterprise Valuation

EV / Earnings -6.13
EV / Sales 11.61
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -6.36

Financial Position

The company has a current ratio of 5.38, with a Debt / Equity ratio of 2.39.

Current Ratio 5.38
Quick Ratio 3.82
Debt / Equity 2.39
Debt / EBITDA n/a
Debt / FCF -0.76
Interest Coverage -19.82

Financial Efficiency

Return on equity (ROE) is -127.42% and return on invested capital (ROIC) is -42.33%.

Return on Equity (ROE) -127.42%
Return on Assets (ROA) -36.61%
Return on Invested Capital (ROIC) -42.33%
Return on Capital Employed (ROCE) -93.86%
Revenue Per Employee 582,413
Profits Per Employee -1.10M
Employee Count 133
Asset Turnover 0.31
Inventory Turnover 1.25

Taxes

In the past 12 months, Saluda Medical has paid 409,172 in taxes.

Income Tax 409,172
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) n/a
Average Volume (20 Days) 1,782,358

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Saluda Medical had revenue of AUD 77.46 million and -146.62 million in losses. Loss per share was -0.88.

Revenue 77.46M
Gross Profit 34.64M
Operating Income -148.59M
Pretax Income -146.21M
Net Income -146.62M
EBITDA -145.76M
EBIT -148.59M
Loss Per Share -0.88

Balance Sheet

The company has 107.60 million in cash and 107.59 million in debt, giving a net cash position of 10,492 or 0.00 per share.

Cash & Cash Equivalents 107.60M
Total Debt 107.59M
Net Cash 10,492
Net Cash Per Share 0.00
Equity (Book Value) 45.05M
Book Value Per Share -3.19
Working Capital 142.66M

Cash Flow

In the last 12 months, operating cash flow was -139.87 million and capital expenditures -1.62 million, giving a free cash flow of -141.49 million.

Operating Cash Flow -139.87M
Capital Expenditures -1.62M
Free Cash Flow -141.49M
FCF Per Share -0.56

Margins

Gross margin is 44.72%, with operating and profit margins of -191.82% and -189.29%.

Gross Margin 44.72%
Operating Margin -191.82%
Pretax Margin -188.76%
Profit Margin -189.29%
EBITDA Margin -188.17%
EBIT Margin -191.82%
FCF Margin n/a

Dividends & Yields

Saluda Medical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -45.81%
FCF Yield -44.20%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Saluda Medical has an Altman Z-Score of -5.94 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -5.94
Piotroski F-Score 1